Price
$77.44-1.90%Social Signal Score
Analyst Ratings
11 analystsRevenue
$0.00Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- John D. Quisel
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 165
- Beta
- 2.05
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- 15.20
Financials
Net Income
$-59.53MEBITDA
$-58.47MFree Cash Flow
$-44.20MEPS (diluted)
$-1.54Shares Outstanding (diluted)
38.69M+2390.2%Operating Expenses
$65.08MCash & Debt
$717.75MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-212.18M | $-6.01 |
| 2024 | $0.00 | $-109.36M | $-3.96 |
| 2023 | $0.00 | $-76.43M | $-3.42 |
| 2022 | $0.00 | $-46.83M | $-45.05 |
| 2021 | $0.00 | $-35.97M | $-44.88 |
| 2020 | $0.00 | $-40.84M | $-27.02 |
Valuation
IRONhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120+50.00%Social Signal Score
Mentions (4)
- Newsseekingalpha.com·21d ago·Positive
Disc Medicine, Inc. (IRON) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Disc Medicine, Inc. (IRON) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsprnewswire.com·28d ago·Negative
IRON, the World's First Advanced General-Purpose Humanoid Robot, Walks off the Production Lines as XPENG's Humanoid Robot Manufacturing Facility Is Officially Commissioned XPENG has officially commissioned its humanoid robot production lines and completed the production-lines manufacturing of the world's first advanced humanoid robot, which autonomously walked off the lines, marking a critical leap from R&D prototyping to production-lines manufacturing. XPENG's humanoid robot production lines fe…
View source ↗ - Newsglobenewswire.com·34d ago·Neutral
Disc Medicine to Participate in Upcoming Investor Conferences WATERTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at four upcoming investor conferences:
View source ↗ - Newsaccessnewswire.com·54d ago·Negative
Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle New name and symbol mark the Company's transformation into a focused, near-term iron developer — anchored by a high-grade, low-carbon, infrastructure-rich project in the heart of one of the world's premier iron ore districts. VANCOUVER, BC / ACCESS Newswire / August 12, 2026 / Bolt Metals Corp. ("Bolt" or the "Company") (CSE:BOLT)(OTCQB:PCRCF)
View source ↗
Earnings
Thu, Nov 5(in 4 weeks)
Consensus estimate $-1.65 per share
Typical surprise -3.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 30$-1.54 vs $-1.71beat
- Tue, May 5$-1.65 vs $-1.55miss
- Thu, Feb 26$-1.62 vs $-1.69beat
- Thu, Nov 6$-1.77 vs $-1.48miss
- Thu, Aug 7$-1.58 vs $-1.17miss
- Wed, May 7$-1.02 vs $-0.99miss
Estimates and results for IRON via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by IRON officers and directors.
- Bought
- —
- Sold
- $21.6m
0 trades
53 trades
- Bitterman Kevinsold
- Bitterman Kevinsold
- Bitterman Kevinsold
- Bitterman Kevinsold
- Bitterman Kevinsold
- Bitterman Kevinsold
- Bitterman Kevinsold
- Bitterman Kevinsold
47 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in IRON.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.